JP2012505881A5 - - Google Patents

Download PDF

Info

Publication number
JP2012505881A5
JP2012505881A5 JP2011532053A JP2011532053A JP2012505881A5 JP 2012505881 A5 JP2012505881 A5 JP 2012505881A5 JP 2011532053 A JP2011532053 A JP 2011532053A JP 2011532053 A JP2011532053 A JP 2011532053A JP 2012505881 A5 JP2012505881 A5 JP 2012505881A5
Authority
JP
Japan
Prior art keywords
oxo
methyl
hydroquinazolin
dihydroquinazolin
dichlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011532053A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012505881A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079975 external-priority patent/WO2010056230A1/en
Publication of JP2012505881A publication Critical patent/JP2012505881A/ja
Publication of JP2012505881A5 publication Critical patent/JP2012505881A5/ja
Withdrawn legal-status Critical Current

Links

JP2011532053A 2008-10-15 2008-10-15 ステアロイル−ＣｏＡデサチュラーゼの阻害剤として使用するための３−ヒドロキナゾリン−４−オン誘導体 Withdrawn JP2012505881A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/079975 WO2010056230A1 (en) 2008-10-15 2008-10-15 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors

Publications (2)

Publication Number Publication Date
JP2012505881A JP2012505881A (ja) 2012-03-08
JP2012505881A5 true JP2012505881A5 (enExample) 2012-11-22

Family

ID=40749129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011532053A Withdrawn JP2012505881A (ja) 2008-10-15 2008-10-15 ステアロイル−ＣｏＡデサチュラーゼの阻害剤として使用するための３−ヒドロキナゾリン−４−オン誘導体

Country Status (4)

Country Link
EP (1) EP2350029A1 (enExample)
JP (1) JP2012505881A (enExample)
CA (1) CA2740389A1 (enExample)
WO (1) WO2010056230A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX343706B (es) 2011-01-31 2016-11-18 Novartis Ag Derivados heterocíclicos novedosos.
BR112014009890A2 (pt) 2011-10-28 2020-10-27 Novartis Ag derivados de purina e seu uso no tratamento de doença
US9695118B2 (en) 2012-04-24 2017-07-04 Chugai Seiyaku Kabushiki Kaisha Benzamide derivative
KR20150003849A (ko) 2012-04-24 2015-01-09 추가이 세이야쿠 가부시키가이샤 퀴나졸린디온 유도체
EP2941426B1 (en) * 2012-12-21 2018-06-13 Gilead Calistoga LLC Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
KR20160073413A (ko) * 2013-10-23 2016-06-24 추가이 세이야쿠 가부시키가이샤 퀴나졸리논 및 이소퀴놀리논 유도체
ES2770123T3 (es) 2015-02-02 2020-06-30 Forma Therapeutics Inc Acidos 3-alquil-4-amido-bicíclicos [4,5,0]hidroxámicos como inhibidores de HDAC
TW201636329A (zh) 2015-02-02 2016-10-16 佛瑪治療公司 作為ｈｄａｃ抑制劑之雙環［４，６，０］異羥肟酸
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors
MA46589A (fr) 2016-10-24 2019-08-28 Yumanity Therapeutics Inc Composés et utilisations de ces derniers
EP3566055B1 (en) 2017-01-06 2025-03-12 Janssen Pharmaceutica NV Scd inhibitor for the treatment of neurological disorders
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
ES3043183T3 (en) 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
MX2021008903A (es) 2019-01-24 2021-11-04 Yumanity Therapeutics Inc Compuestos y usos de los mismos.
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
IN202011027502A (enExample) 2020-06-29 2021-12-31 Council Scient Ind Res

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020073A1 (en) * 1989-07-03 1991-01-04 Eric E. Allen Substituted quinazolinones as angiotensin ii antagonists
US6638937B2 (en) * 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
US6894057B2 (en) * 2002-03-08 2005-05-17 Warner-Lambert Company Oxo-azabicyclic compounds
US20040142950A1 (en) * 2003-01-17 2004-07-22 Bunker Amy Mae Amide and ester matrix metalloproteinase inhibitors
BRPI0515482A (pt) * 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
CN102861019B (zh) * 2004-12-24 2016-05-25 诺华股份有限公司 治疗或预防神经性疼痛的药物
WO2006125180A1 (en) * 2005-05-19 2006-11-23 Xenon Pharmaceuticals Inc. Piperazine derivatives and their uses as therapeutic agents

Similar Documents

Publication Publication Date Title
JP2012505881A5 (enExample)
JP2010523674A5 (enExample)
CA2683925A1 (en) 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
JP2008535871A5 (enExample)
EP0914319B1 (en) Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
JP2008537741A5 (enExample)
JP2011516498A5 (enExample)
KR101237623B1 (ko) 벤즈이미다졸 유도체, 이의 제조방법, ｆｘｒ 작용물질로서이의 용도, 및 이를 함유하는 약학 제제
JP2004520292A5 (enExample)
RU2013106755A (ru) 1,4,5,6-тетрагидропиримидин-2-иламины
JP2009514878A5 (enExample)
JP2001522802A (ja) 大腸ポリープを治療するためのチロシンキナーゼインヒビターとしてのキナゾリン誘導体の使用
JP2005527602A5 (enExample)
RU2009118825A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1ГИДРОКСИЭТИЛ)ФЕНОЛА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JP2005538955A5 (enExample)
RU2007141892A (ru) 5-метил-1-(замещенный фенил)-2-(1н)-пиридон для производства медикаментов для лечения фиброза в органах и тканях
JP2010523653A5 (enExample)
JP2014502979A5 (enExample)
JP2005519897A5 (enExample)
RU2008115539A (ru) Производные гидразона и их применение
JP2010533160A5 (enExample)
RU2011149635A (ru) Карбоксамидные соединения и их применение в качестве ингибиторов кальпаина
RU2007146798A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
RU2012139828A (ru) Производные пиразолопиперидина в качестве ингибиторов nadph-оксидазы
JP2016528276A (ja) プラーク退縮を促進するための組成物及び治療法